-ONSITE REGISTRATION IS AVAILABLE!-
A Technology Transfer and Federal Marketplace Event
PREVENTING, DIAGNOSING AND TREATING CANCER
Working with Industry to Promote Public Health
-Featuring National Cancer Institute (NCI) Technologies-
Click Here for Showcase Flyer
Detailed Agenda
Date: September 25, 2007
Time: 7:00 am - 04:00 pm (Networking Reception, 2:30 pm - 4:00 pm)
Cost: $60. REGISTRATION EXTENDED TO FRIDAY, SEPTEMBER 21!
Location: Marriott Bethesda North Hotel and Conference Center (Salons E-H)
Address: 5701 Marinelli Road, North Bethesda, MD 20852
Parking will be complementary with a voucher that will be supplied upon arriving at the event. Use Executive Boulevard lot. For driving and METRO directions, click here.
NOTE: Click here for links to nearby hotels as the Conference Center is sold out during the period of our event.
ABOUT THE SHOWCASE:
Based in Maryland, the National Cancer Institute (NCI) is the world's largest organization dedicated to cancer research. The research arm of NCI's intramural program is the Center for Cancer Research (CCR), an organization of scientists, physicians, trainees, and support staff dedicated to making fundamental discoveries in the prevention, diagnosis, and treatment of cancer and HIV/AIDS.
Many CCR innovations, which already have been transferred out of the lab, have evolved into new treatments and technologies to improve the lives of patients today. This marketplace event showcases new opportunities for technology transfer to occur.
Learn more about the CCR at http://ccr.cancer.gov .
SPOTLIGHT ON SHOWCASE PRESENTERS!
Learn more about two of many industry leaders that will be presenting at the showcase:
* Dr. Steven Rosenberg
Presentation: Cell Transfer Immunotherapy: Treatment of Patients with Metastatic Cancer
About: Dr. Rosenberg has had a 34 year career at NCI and has trained more than four dozen of today's Chiefs of Surgical Oncology nationwide as well as made numerous other contributions to NCI. Read more.
* Dr. Thomas Waldman
Presentation: IL-15 as a Therapy for Metastatic Cancer and the IL-15 Receptor as a Target for Immunotherapy of Lymphoma and Autoimmune Diseases
About: Dr. Waldman, along with his many other accomplishments, pioneered and propelled the use of monoclonal antibodies for immunotherapy. Read more.
For registration questions, contact Mark Glazer
240-243-4045
mglazer@techcouncilmd.com
For program questions, contact Ron Kaese
410-715-4170
rkaese@marylandtedco.org
HOST ORGANIZATIONS:
TEDCO
Tech Council of Maryland
National Cancer Institute
Department of Health and Human Services
National Institutes of Health
CORPORATE SPONSOR:
NeoSystems
PNC
RECEPTION SPONSOR:
Montgomery County Department of Economic Development
SUPPORTING ORGANIZATIONS:
Biotechnology Industry Organization
Entrepreneur Center at Northern Virginia Tech Council
Federal Laboratory Consortium
Fort Detrick Business Development Office
Frederick County Office of Economic Development
Maryland Business Incubation Association
Maryland Department of Business and Economic Development
Maryland Small Business Development Center
MMG Group
Rockville Economic Development Inc.
Women In Bio
|
